Skip to main content

Table 1 Dual effect of MSCs on HCC

From: Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways

References

Effects

Cell lines

Results

Hou et al. [11]

Inhibit

HEK 293 and HepG2 cell lines

Wnt signaling pathway may have a function in MSC-mediated tumor cell inhibition

Yan-rong Lu et al. [113]

Inhibit

murine hepatoma H22, lymphoma (YAC-1 and EL-4) and rat insulinoma INS-1 cell lines

MSCs had potential inhibitory effects on tumor cell growth in vitro and in vivo without host immunosuppression, by inducing apoptotic cell death and G0/G1 phase arrest of cancer cells

Li et al. [132]

Inhibit

MHCC97-H cell line

MSC could be useful in controlling metastatic recurrence of HCC

Zhao et al. [133]

Inhibit

HepG2, Huh7, SMMC7721, and Bel7402 cell lines

inhibited HCC cell proliferation and division induced HCC cell death through the downregulation of Akt signaling

El Asmar et al. [105]

Inhibit

DENA and CCl4 induction in rat model

tumor suppressive effects as evidenced by down regulation of Wnt signaling target genes concerned with anti-apoptosis, mitogenesis, cell proliferation and cell cycle regulation

Li et al. [134]

Inhibit

MHCC97-H cell line

The metastatic potential of tumor cells was downregulated after hMSC engraftment and hMSCs induce further tumor cells apoptosis

Qiao et al. [135]

Inhibit

H7402 and HepG2 cell lines

The Wnt signaling pathway may have a role in hMSC-mediated targeting and tumor cell inhibition

Qiao et al. [69]

Inhibit

H7402 cell line

NF‐κB downregulation is one of reasons for the depression of tumor cell proliferation mediated by hMSCs

Bruno et al. [136]

Inhibit

HepG2 cell line

MVs from human MSCs inhibited in vitro cell growth

Ma et al. [137]

Inhibit

H22 cell line

BMSCs pulsed with TEX could enhance its antitumor activities

Abd-Allah et al. [138]

Inhibit

HEPA 1-6 cell line

MSCs could inhibit cell division of HCC and potentiate their death

Seyhoun et al. [139]

Inhibit

HepG2 cell line

Combination therapy MSCs and sorafenib to the treatment of HCC that significantly improves the results

Hajighasemlou et al. [140]

Inhibit

HepG2 cell line

Local injection of MSCs can be used as cell therapy to fight neoplasms

Hernanda et al. [141]

Promote

Huh7 cell line

MSCs are enriched in human HCC tumor compartment and could exert trophic effects on tumor cells

Yan et al. [142]

Promote

MHCC97L cell line

HCC progression, and may be a potential therapeutic target

Gong et al. [143]

Promote

HepG-2 cell line

promote the growth of microvascular in hepatoma cells

Jing et al. [144]

Promote

SMMC-7721 cell line

MSCs in tumor inflammatory microenvironment could promote tumor metastasis through TGFβ-induced EMT

Bhattacharya et al. [145]

Promote

SK-Hep1 cell line

stimulation of cancer-associated fibroblasts and EMT markers

Liu et al. [146]

Promote

HCCLM3 cell line

significantly enhance the tumor cell metastasis, which was due to the EMT of HCC cells induced by TGF-β

  1. CCl4 carbon tetrachloride, DENA diethylenetriamine, EMT epithelial to mesenchymal transition, HCC Hepatocellular carcinoma, hMSCs human mesenchymal stem cells, MVs Microvesicles, TGF-β transforming growth factor beta